| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMA/435707/2011 (1.6.11) |
| Publication Date | 01/06/2011 |
| Content Type | News |
|
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), on 1 June 2011, released a guidance document on the identification of commercially confidential information and protection of personal data within the structure of the marketing-authorisation dossier for public consultation. The draft document, which is open for comment until 1 September 2011, outlines the types of information included in marketing-authorisation applications that can be released following a request for access to documents, once a marketing authorisation has been granted. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/06/news_detail_001267.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Health, Internal Markets, Politics and International Relations |
| Countries / Regions | Europe |
